Featured Story Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System February 27, 2024-Aria CV
PanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancer June 17, 2021-PanTher Therapeutics
Sera Prognostics and Anthem, Inc. Announce Commercial Partnership Leveraging Innovative Biomarker Test to Reduce Risk of Preterm Birth May 19, 2021-Sera Prognostics
Evaluation of Health and Economic Benefit of the PreTRM® Test-And-Treat Strategy to Improve Maternal and Infant Health Among Commercially Insured in the US May 18, 2021-Sera Prognostics
Instylla Announces Enrollment of Initial Patients in the Embrace™ Hydrogel Embolic System Global Randomized Multi-Center Clinical Trial March 30, 2021-Instylla Inc.
Saphena Medical’s Venapax® EVH System Awarded Sole Supplier Contract With Premier® Inc.’s SURPASS™ Purchasing Program January 5, 2021-Saphena Medical
Saphena Medical’s Venapax® EVH System Awarded Sole-Supplier Contract With Premier Inc.’s ASCEND Purchasing Program December 7, 2020-Saphena Medical